Results 131 to 140 of about 409,058 (151)

[Circulating serum STN antigen as a prognostic marker in epithelial ovarian cancer].

Gan to kagaku ryoho. Cancer & chemotherapy, 1991
Circulating serum sialyl Tn (STN) antigen levels were measured in 89 patients with epithelial ovarian cancer. Survival at 5 years for patients with STN-negative (serum STN levels less than 50 U/ml) versus STN-positive tumors (serum STN levels greater than or equal to 50 U/ml) was 76.9% versus 10.8%, respectively (p less than 0.05). The overall survival
H, Kobayashi, T, Terao, Y, Kawashima
openaire   +1 more source

[Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group].

Gan to kagaku ryoho. Cancer & chemotherapy, 1991
Serum sialyl Tn antigen was assayed in gynecological cancer and benign patients by means of "STN OTSUKA" kits. Fifty-eight of 140 (41.1%) ovarian cancer patients showed a significant elevation of sialyl Tn antigen in serum above the cut-off level of 45 unit/ml (mean +2SD) determined from normal controls.
K, Noda, M, Shiota, O, Tanizawa, M, Inoue, Y, Tenjin, T, Sugishita, M, Yakushiji, T, Miyoshi, S, Nozawa, T, Sakuma   +9 more
openaire   +1 more source

[Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl TN antigen: (2). Evaluation of clinical significance. STN Study Group].

Gan to kagaku ryoho. Cancer & chemotherapy, 1989
The clinical significance of serum sialyl Tn antigen as a tumor marker was evaluated using "STN Otsuka" kits. Results indicated that the antigen was frequently elevated in sera from patients with ovarian cancers (43.1%, 140/325), including serous cystadenocarcinoma (51.6%, 63/122), mucinous cystadenocarcinoma (55.6%, 30/54), endometrioid carcinoma (56 ...
H, Imura, T, Mori, H, Ohkura, M, Ishii, H, Ariyoshi, J, Endo, M, Kitao, I, Takeda, H, Kobayashi, M, Inoue   +9 more
openaire   +1 more source

[Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl Tn antigen: (1). Evaluation of assay conditions and normal values. STN Study Group].

Gan to kagaku ryoho. Cancer & chemotherapy, 1989
An immunoradiometric competitive inhibition assay of the serum levels of the sialyl Tn antigen using "STN Otsuka" kits is described. The assay required only duplicate 50-microliters samples, and the concentration of sialyl Tn antigen in serum was determined by reference to a standard curve ranging from 0 to 400 arbitrary units/ml.
H, Imura, T, Mori, H, Ohkura, M, Ishii, H, Ariyoshi, J, Endo, M, Kitao, I, Takeda, H, Kobayashi, M, Inoue   +9 more
openaire   +1 more source

Non-invasive colon cancer screening utilizing STn antigen

Gastroenterology, 2003
Eric C. Chu, Keshab D. Pant, John D. McCracken   +2 more
openaire   +1 more source

Critical care management of chimeric antigen receptor T-cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Sandrine Valade, Peter Schellongowski, Alexander Shimabukuro-Vornhagen   +2 more
exaly  

Chimeric antigen receptor T-cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Sagar Lonial, Rujul Parikh
exaly  

Ferrocene-derivative Electrochemical Probe for the Selective Detection of Carcinoma-associated STn Antigen

Electroanalysis, 2022
Maria Luísa Soares da Silva
exaly  

Construction and validation of a biosensor for cancer-associated STn antigen

Biosensors and Bioelectronics, 2014
Catarina Gomes, Leonor David
exaly  

Synthetic and Immunological Studies of sTn Derivatives Carrying Substituted Phenylacetylsialic Acids as Cancer Vaccine Candidate

ACS Medicinal Chemistry Letters, 2011
Zhongwu Guo, Qianli Wang
exaly